Skip to content
Boca Raton City Online – Lifestyle
Author:
Unicycive Therapeutics, Inc.
Foundayo™ (orforglipron), Lilly’s new oral GLP-1 pill for weight loss, now available in the U.S.
April 9, 2026
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 9, 2026
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
March 4, 2026
←
Previous Page
1
2
3